Who owns CG Oncology, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CGON from SEC Form 13F filings across 234 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 234 institutions disclosed 93.0M shares of CG Oncology, Inc. worth $6.59B — about 104.7% of shares outstanding; the largest disclosed holder is RTW INVESTMENTS, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
234
13F holders
$6.59B
value, 2026 filers
104.7%
of shares outstanding (93.0M sh)
40
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CGON's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RTW INVESTMENTS, LP | 8.5M | $603.6M | 6.1% | 9.6% | 0.0% |
| 2 | T. Rowe Price Investment Management, Inc. | 6.7M | $476.9M | 0.3% | 7.6% | +1.7% |
| 3 | Decheng Capital LLC | 6.4M | $451.7M | 65.9% | 7.2% | 0.0% |
| 4 | BlackRock, Inc. | 6.3M | $450.0M | 0.0% | 7.1% | +1.5% |
| 5 | WELLINGTON MANAGEMENT GROUP LLP | 4.9M | $348.6M | 0.1% | 5.5% | -7.7% |
| 6 | FMR LLC | 4.6M | $325.7M | 0.0% | 5.2% | +10.4% |
| 7 | TCG Crossover Management, LLC | 3.7M | $260.2M | 7.4% | 4.1% | 0.0% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 3.6M | $253.4M | 0.0% | 4% | +7.8% |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.5M | $249.2M | 0.0% | 4% | +1.5% |
| 10 | STATE STREET CORP | 3.2M | $229.3M | 0.0% | 3.6% | -5.9% |
| 11 | PRICE T ROWE ASSOCIATES INC /MD/ | 3.1M | $220.2M | 0.0% | 3.5% | -18.4% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 2.2M | $157.8M | 0.0% | 2.5% | +3.4% |
| 13 | Foresite Capital Management VI LLC | 2.1M | $149.5M | 26.4% | 2.4% | -11.0% |
| 14 | Seven Fleet Capital Management LP | 1.9M | $133.7M | 26.1% | 2.1% | 0.0% |
| 15 | EcoR1 Capital, LLC | 1.9M | $132.7M | 5.9% | 2.1% | +25.3% |
| 16 | MORGAN STANLEY | 1.5M | $106.3M | 0.0% | 1.7% | +27.4% |
| 17 | DV Trading LLC | 1.4M | $102.0M | 3.3% | 1.6% | 0.0% |
| 18 | Avidity Partners Management LP | 1.3M | $95.6M | 19.6% | 1.5% | -3.6% |
| 19 | BANK OF AMERICA CORP /DE/ | 1.3M | $92.1M | 0.0% | 1.5% | +31.9% |
| 20 | ALLIANCEBERNSTEIN L.P. | 1.2M | $87.2M | 0.0% | 1.4% | -10.5% |
| 21 | GOLDMAN SACHS GROUP INC | 1.1M | $80.6M | 0.0% | 1.3% | +32.5% |
| 22 | ACORN CAPITAL ADVISORS, LLC | 1.1M | $80.2M | 22.0% | 1.3% | 0.0% |
| 23 | Foresite Capital Management V, LLC | 1.1M | $76.5M | 26.5% | 1.2% | 0.0% |
| 24 | FRANKLIN TEMPLETON INC | 1.0M | $69.8M | 0.0% | 1.2% | -21.5% |
| 25 | Logos Global Management LP | 975,000 | $69.1M | 3.7% | 1.1% | -2.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.